The fact that tumors are targeted and controlled by CD8+ T cells is suggested by the increased tumor incidence in immunosuppressed patients [9], [10], [11] and by the fact that tumor-specific immunity can be detected in cancer patients [12], [13], [14], [15]. The gene discussed is CD8A; the disease is neoplasm.